Cosmos Holdings, Inc. Announces Second Quarter 2018 Results
Financial Highlights for the three months ended June 30, 2018: Revenues were $8.8 million, a 45% increase, as compared to $6.1 million for the same period the prior year. Gross profit was $702 thousand, a 46% increase, as compared to $480 thousand for the same period the prior year. ...
Cosmos Holdings, Inc. Announces First Quarter 2018 Results
Highlights: Quarter ended March 31, 2018, versus the quarter ended March 31, 2017, revenue improved 191% to $11.9 million from $4.1 million. Gross profit increased 67.7% to $609,996 in the first quarter of 2017 from $363,692 in the first quarter of 2016. Debt refinancing in the amount of $3,199,728 from interest rate of ten (10%) percent per annum was adjusted to ...
Cosmos Holdings, INC. Releases its New Nutraceutical Brand
Cosmos Holdings, Inc., through its wholly owned subsidiary Sky Pharm S.A., offers a first look at its Sky Premium Life® Brand of food supplements. CHICAGO, IL- - April 19, 2018 - Cosmos Holdings, Inc. (OTCQB: COSM), released the design and packaging of its first set of dietary supplements. These premium supplements boast a sleek design and packaging along with best in class formulation. The line of more than 60 products is based on ...
Cosmos Holdings, Inc. Announces Year End 2017 Financial Results
CHICAGO, April 20, 2018 - Cosmos Holdings, Inc. (Cosmos) (COSM), an international pharmaceutical company, announced today its full-year 2017 financial results for the year ended December 31, 2017. Full-year 2017 revenue increased 347% to $30.0 million from $6.7 million in 2016, fueled by strong execution on customer network expansion and by securing approximately $10.2 million in additional capital. Cosmos also achieved gross profit growth of 225% in 2017, an increase to $1.95 million in 2017 from ...
Cosmos Holdings Signs Marathon Global Inc. for Exclusive Cannabis Product Distribution Throughout Europe
CHICAGO, IL March 21, 2018 - COSMOS HOLDINGS INC. (COSM) (“Company”) is pleased to announce that it has signed a definitive agreement with Marathon Global Inc. to source and procure medical cannabis products and their derivatives for clients of Cosmos in approved Countries in Cosmos’ distribution network of approximately 35,000 pharmacies across Europe. “Marathon Global is superbly positioned within the global Cannabis industry and views the underserviced European market as a tremendous opportunity,” says Gavin Treanor, Marathon ...
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.